IP Library Granted Patent US 7,524,500
Granted Patent B2
US 7,524,500 · App. 10/471,604 · Granted Apr 28, 2009

Method of stimulating stem cells

Assignee: Therapure Biopharma Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,524,500
App. No.
10/471,604
Granted
Apr 28, 2009
Kind
B2
Abstract

Methods and compositions for stimulating the growth, proliferation, differentiation and/or mobilization of stem and/or progenitor cells are described. The method involves administering an effective amount of a substance which can activate the CD163 hemoglobin scavenger receptor signal transduction pathway. The methods and compositions are useful in stimulating hematopoiesis and in treating a wide range of conditions including cytopenias, anemias and for use in preparing cells for transplantation.

Claims (6)

1. A method of stimulating the growth, proliferation, and/or differentiation of a stem cell that expresses CD163 comprising administering an effective amount of an antibody or fragment thereof that can activate CD163 on the stem cell to the cell or an animal in need thereof.

2. The method according to claim 1 wherein the stem cell is a CD34 positive cell.

3. The method according to claim 1 for the stimulation of hematopoiesis.

4. The method according to claim 1 wherein the stem cell is an erythroid progenitor cell.

5. The method according to claim 1 wherein the stem cell is a myeloid progenitor cell.

6. The method according to claim 1 wherein the antibody or fragment thereof binds to the CD163 on the stem cell.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Oct 21, 2020
From: MIDCAP FINANCIAL TRUST
To: THERAPURE BIOPHARMA INC.
Reel/Frame 054123/0837 →
SECURITY INTEREST Recorded Nov 23, 2015
From: THERAPURE BIOPHARMA INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037116/0471 →
VESTING ORDER Recorded Dec 30, 2008
From: HEMOSOL LP
To: 2140304 ONTARIO INC.
Reel/Frame 022034/0536 →
CHANGE OF NAME Recorded Dec 30, 2008
From: 2140304 ONTARIO INC.
To: HEMOSOL BIOPHARMA INC.
Reel/Frame 022034/0592 →
CHANGE OF NAME Recorded Dec 30, 2008
From: HEMOSOL BIOPHARMA INC.
To: THERAPURE BIOPHARMA INC.
Reel/Frame 022034/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2005
From: MUELLER, SUSAN; BELL, DAVID; MATTHEWS, KATHRYN EMMA
To: HEMOSOL LP
Reel/Frame 015619/0362 →
Continuity (3)
Provisional Application 6034179300 · Dec 21, 2001
Provisional Application 6027845300 · Mar 26, 2001
Related Publication 20040151692A1 · Aug 5, 2004